NCT00567684Active, not recruiting
Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors
Pilot Study Assessing the Technical Efficacy of Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) With Particular Focus on Patients at Risk of Urothelial Tumors
Source: ClinicalTrials.gov · Last updated 7 Oct 2026
Brief summary (registry, in English)
The goal of this clinical research study is to use computed tomography urography (CTU) scans and intravenous urography (IVU) scans to check the status of urothelial cancer, in order to try to learn the level of effectiveness of possibly using CTU by itself in future patients.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 133 (actual)
- First submitted
- 3 Dec 2007
- Start date
- 15 Nov 2007
- Primary completion date
- 30 Nov 2034
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Bladder cancer
- NCT number
- NCT00567684
What you commit to
- Study type: Interventional
- Participants enrolled: 133
- From 15 Nov 2007 to the primary completion date, 30 Nov 2034
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Patients who will undergo IVU using digital tomosynthesis and staging abdomino-pelvic CT as part of their routine care will be invited to participate in this study.
- Patients who have been referred for CTU will also be invited to participate in the study.
- Such patients will typically
- Have histologically proven TCC, or
- Have bladder tumors of Stage ≥ T3, or
- Had cystectomies for bladder cancer, or
- Upper tract TCC.
- \>18 years age.
- Written informed consent will be obtained from patients.
- Patient exclusion criteria:
- Elevated serum creatinine of \>2
- Allergy to intravenous CT contrast media
- Ureteral stint present or removed within six weeks
- Women of child bearing potential
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Texas - MD Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.